AS - 医索

找到约 2676 条结果

Niraparib and Dostarlimab efficacy in patients with platinum.sensitive relapsed mesothelioma MlST5, a phase lla clinicaltrial

医客学院 - 会议报告集

Molecular residual disease analysis from the ADAURA trial of adjuvant osimertinib in patients with resected EGFR-mutated stage lB-lllA non-small cell lung cancer

医客学院 - 会议报告集

Lorlatinib in TKl naive, advanced RoS1-positivenon-small cell lung cancer a multicenter, open-label, single-arm, phase 2 trial

医客学院 - 会议报告集

Ivonescimab combined with chemotherapy in patientswith EGFR-mutant non-squamous non-small cell lungcancer who progressed on EGFR-TKls treatment arandomized, double-blind, multi-center, phase 3 trial(HARM

医客学院 - 会议报告集

ICARUS-LUNG01 A phase 2 Study of Dato-DXd inpatients with previously treated advanced NSCLc, withsequential tissue biopsies and biomarkers analysis topredict treatment outcome

医客学院 - 会议报告集

Health-Related Quality of Life Outcomes From the Randomized, Double-Blind Phase 3 KEYNOTE-671 Study of Perioperative Pembrolizumab for Early-Stage NSCLC

医客学院 - 会议报告集

Feasibility and safety of neoadjuvant nivolumab and chemotherapy for resectable diffuse pleural mesotheliomas (DPM) Results of a prospective pilot study

医客学院 - 会议报告集

EFFICACY AND SAFETY OF TALETRECTINIB INPATIENTS WITH ADVANCED OR METASTATICROS1 NON-SMALL CELL LUNG CANCER THEPHASE 2 TRUST-I STUDY

医客学院 - 会议报告集

EFFICACY AND SAFETY OF SIGVOTATUGVEDOTIN, AN INVESTIGATIONAL ADC, IN NSCLCUPDATED PHASE 1 RESULTS(SGNB6A-001)

医客学院 - 会议报告集

Efficacy and Safety of Erdafitinib in Adults WithNSCLC and Prespecified Fibroblast Growth FactorReceptor Alterations in the Phase 2 Open-labelSingle-arm RAGNAR Trial

医客学院 - 会议报告集

今日实时热搜